Asia Pacific Medical Cyclotron Market to Grow at a CAGR of 4.2% to reach US$ 51.45 million from 2020 to 2027
The Asia Pacific medical cyclotron market is expected to reach US$ 51.45 million to 2027 from US$ 37.34 million in 2019, it is estimated to grow with a CAGR of 4.2% from 2020 to 2027.
The growth of the market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination toward nuclear scans for accurate diagnosis. However, the high cost coupled with the procedures hinder the market growth.
A cyclotron is an electrically powered machine that produces a beam of charged particles for industrial, research, and medical purposes. In medical applications, cyclotrons have rays that are used to manufacture radioisotopes for medical imaging. Various medical cyclotrons are being used for the production of SPECT and Positron Emission Tomography (PET) isotopes used for therapeutic and other medical applications. Cyclotrons can be used in particle therapy to treat cancer by penetrating ion beams inside the body to remove tumors with radiation. Besides, proton beam therapy is used to treat tumors that do not spread in the body and, thus, do not require surgery. The prevalence of cancer is increasing every year. As per estimates by the Globocan 2018: India Factsheet, there were 1,157,294 new cancer cases and 784,821 cancer deaths in 2018. Increasing prevalence of chronic diseases like cancer, rising development of artificial radionuclides, and surging number of cancer treatment therapies are driving the Asia Pacific medical cyclotrons market.
Amid the COVID-19 outbreak, the demand for medical cyclotrons is declined as patients are at higher risk of exposure. In Asia Pacific, healthcare facilities are limiting or cancelling surgeries and sometimes screenings or other treatments if it is not recognized as a life-threatening condition. Therefore, the outbreak is likely to restrain the growth of the Asia Pacific medical cyclotron market.
Asia Pacific Medical CyclotronMarketRevenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Asia PacificMedical Cyclotron MarketSegmentation
By Type
- Ring Cyclotron
- Azimuthally Varying Field (AVF)
By Capacity
- 10-12 MeV
- 16-18 MeV
- 19-24 MeV
- 24 MeV and Above
By End User
- Hospitals
- Specialized Clinics
- Pharmaceutical Companies
- Other End User
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- General Electric Company
- Varian Medical Systems, Inc
- IBA
- Sumitomo Heavy Industries, Ltd.
- Siemens AG
- Advanced Cyclotron Systems
- isoSolution Inc
Asia Pacific Medical Cyclotron Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 37.34 Million |
| Market Size by 2027 | US$ 51.45 Million |
| Global CAGR (2020 - 2027) | 4.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type , Capacity, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
- General Electric Company
- Varian Medical Systems, Inc
- IBA
- Sumitomo Heavy Industries, Ltd.
- Siemens AG
- Advanced Cyclotron Systems
- isoSolution Inc
Get Free Sample For